A Smart + Strong Site
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Marijuana and its CD4 Receptors: A New HIV Treatment Strategy?
Pathway to a Cure: Cancer Drug Helps Purge HIV From Resting Cells
Life Expectancy With HIV Increases Dramatically
Undetectable Viral Load? Not Necessarily in Semen
Engineering CD8 Cells to Kill HIV in Tissues
Pathway to a Cure: Positive Results Continue for Sangamo's CCR5 Gene Therapy
Revised U.S. Guidelines: HIV Treatment is Recommended for All People Living With HIV
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailprint

June 9, 2008

Syphilis Treatment Response Improves With HIV Therapy

Combination antiretroviral (ARV) therapy significantly improves syphilis treatment response rates in HIV-positive people undergoing their first course of antibiotics, according to the authors of a study to be published in Clinical Infectious Diseases.

HIV can severely weaken the immune system, making it harder for medications to treat other infections and diseases. The impact of HIV-related immune suppression on the response to syphilis treatment, however, isn’t well understood. Current recommendations for the treatment of syphilis are the same for HIV-positive patients as HIV-negative patients, regardless of the health of a patient’s immune system.

Khalil Ghanem, MD, and his colleagues from Johns Hopkins School of Medicine, in Baltimore, set out to determine whether the degree of immune suppression—and the use of ARV treatment—have an impact on responses to syphilis therapy. They examined the medical records of 180 HIV-positive patients diagnosed with syphilis between 1990 and 2006. The majority of the patients were treated with penicillin.

Of the 180 patients, 39 percent experienced a syphilis treatment failure—they either failed to attain a major reduction in their syphilis antibody levels or they had a good initial antibody response that later increased again. Ghanem’s team found that people who had a CD4 count of less than 200 at the time of their syphilis diagnosis were nearly 2.5 times more likely to experience a syphilis treatment failure as people with a CD4 count above 200.

Ghanem’s group also found that combination ARV treatment reduced the risk of syphilis treatment failure by 60 percent. The more the CD4 count recovered after starting ARV treatment, they found, the greater the reduction in syphilis treatment failure risk. Ghanem’s team writes that further research on the interaction between HIV, ARV treatment and syphilis should be conducted, but that “aggressive HIV infection management” could improve syphilis treatment responses in people with HIV.

Search: syphilis, Khalil Ghanem, Johns Hopkins, penicillin


Scroll down to comment on this story.

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

       


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine


    CuteBoyinQns
    Jackson Heights
    New York


    Sin_Grinder
    Genoa
    Nevada


    cortaza100
    milwaukee
    Wisconsin


    daino1972
    Columbus
    Ohio
Click here to join POZ Personals!
Conference Coverage

19th Conference on Retroviruses and Opportunistic Infections (CROI 2012)
Seattle, Washington
March 5 - 8, 2012


6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011)
Rome, Italy
July 17 - 20, 2011


18th Conference on Retroviruses and Opportunistic Infections (CROI 2011)
Boston, MA
February 27 - March 2, 2011


more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.